The same treatments also decreased the glycosylated fraction of GLUT4-eGFP fusion protein associated with the vesicles, further suggesting that in glioblastoma cells PARP1 has a role in GLUT/SLC2As trafficking. This evidence concerns the gene SLC2A1 and glioblastoma.